PMEL and smooth muscle tumor: IHC may be particularly helpful in excluding histological mimics such as angiomyolipoma (HMB-45 positive), atypical lipomatous tumors (MDM2/CDK4 positivity), or other smooth muscle tumors with ambiguous features [18].